Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - MMP Revenue Summary

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

lambertslunatics

Rank: President [?]

Points: 21916 [?]

Votes: 164 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

MMP Revenue Summary - $293.6M Total

posted on Jan 12, 2010 12:19PM


	Prior to Merger	2006	2007	2008	2009	2010	Totals
Revenues	$ 23,050,000	$ 60,000,000	$ 110,878,985	$ 59,282,971	$ 29,392,424	$ 11,023,655	$ 293,628,035
Operating expenses	$ -	$ 4,486,955	$ 12,189,575	$ 18,627,032	$ 7,793,472	$ 4,035,901	$ 47,132,935
Operating income	$ 23,050,000	$ 55,513,045	$ 98,689,410	$ 40,655,939	$ 21,598,952	$ 6,987,754	$ 246,495,100
Interest income	$ -	$ 183,682	$ 421,407	$ 216,902	$ 58,987	$ 380	$ 881,358
Income before Taxes	$ 23,050,000	$ 55,696,727	$ 99,110,817	$ 40,872,841	$ 21,657,939	$ 6,988,134	$ 247,376,458
Provision for Taxes	$ -	$ -	$ 11,790	$ 11,790	$ 11,790	$ -	$ 35,370
Net Income	$23,050,000	$55,696,727	$99,099,027	$ 40,861,051	$21,646,149	$ 6,988,134	$247,341,088

Moore & TPL's Portion	$ 11,525,000	$ 27,848,364	$ 49,549,514	$ 20,430,526	$ 10,823,075	$ 3,494,067	$ 123,670,544
PTSC's Portion	$ 11,525,000	$ 27,848,364	$ 49,549,514	$ 20,430,526	$ 10,823,075	$ 3,494,067	$ 123,670,544